Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment

Enzalutamide is a nonsteroidal inhibitor of the androgen receptor (AR) signaling pathway and is used to treat patients with metastatic castration-resistant prostate cancer. However, the risk of cardiovascular-related hospitalization in patients with no contraindications for the use of enzalutamide i...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales, Manuel, Martín-Vasallo, Pablo, Ávila, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220762/
https://www.ncbi.nlm.nih.gov/pubmed/35740293
http://dx.doi.org/10.3390/biomedicines10061271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220762/
https://www.ncbi.nlm.nih.gov/pubmed/35740293
http://dx.doi.org/10.3390/biomedicines10061271

Ejemplares similares